https://www.askgileadmedical.com/2026-01-26https://www.askgileadmedical.com/about/2026-01-26https://www.askgileadmedical.com/search/2026-01-26https://www.askgileadmedical.com/publications/2026-01-26https://www.askgileadmedical.com/medications/2026-01-26https://www.askgileadmedical.com/len4prep/2026-01-26https://www.askgileadmedical.com/len4prep/understanding/2023-08-24https://www.askgileadmedical.com/len4prep/dosing-admin/2023-08-24https://www.askgileadmedical.com/len4prep/ongoing-care/2023-08-24https://www.askgileadmedical.com/len4prep/access/2023-08-24https://www.askgileadmedical.com/docs/veklury/veklury-use-of-covid-19-vaccines2026-03-25https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-continuous-renal-replacement-therapy2026-03-19https://www.askgileadmedical.com/docs/trodelvy/trodelvy-resistance2026-03-18https://www.askgileadmedical.com/docs/veklury/veklury-hepatic-safety2026-03-17https://www.askgileadmedical.com/docs/veklury/veklury-coring-during-dose-preparation2026-03-12https://www.askgileadmedical.com/docs/zydelig/zydelig-storage-and-stability2026-03-11https://www.askgileadmedical.com/docs/trodelvy/trodelvy-incidence-and-management-of-rash2026-03-31https://www.askgileadmedical.com/docs/descovy/descovy-use-in-bariatric-surgery2026-03-17https://www.askgileadmedical.com/docs/trodelvy/trodelvy-health-related-quality-of-life-in-mtnbc2026-03-31https://www.askgileadmedical.com/docs/yeztugo/yeztugo-time-to-protection2026-03-11https://www.askgileadmedical.com/docs/vemlidy/vemlidy-aasld-guidelines-for-chronic-hepatitis-b2026-03-26https://www.askgileadmedical.com/docs/epclusa/epclusa-retreatment-of-hcv-patients-after-previous-sof-vel-use2026-03-11https://www.askgileadmedical.com/docs/zydelig/zydelig-crushing-or-splitting-tablets2026-03-26https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-development-of-resistance2026-03-11https://www.askgileadmedical.com/docs/truvada/truvada-for-prep-time-to-protection2026-03-17https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-combination-with-pembro-in-patients-with-1l-pd-l1%2B-mtnbc2026-03-16https://www.askgileadmedical.com/docs/veklury/veklury-specific-gravity2026-03-12https://www.askgileadmedical.com/docs/vemlidy/vemlidy-use-in-fatty-liver-disease2026-03-19https://www.askgileadmedical.com/docs/biktarvy/biktarvy-study-40302026-03-12https://www.askgileadmedical.com/docs/biktarvy/biktarvy-in-participants-with-hiv-hbv-co-infection2026-03-19https://www.askgileadmedical.com/docs/veklury/veklury-use-in-dialysis2026-03-25https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-pregnancy2026-03-24https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-baseline-nrti-resistance2026-03-19https://www.askgileadmedical.com/docs/yeztugo/yeztugo-coadministration-with-fentanyl2026-03-11https://www.askgileadmedical.com/docs/trodelvy/tro-2l-monotherapy-use-in-cisplatin-or-platinum-ineligible-muc2026-03-24https://www.askgileadmedical.com/docs/biktarvy/biktarvy-efficacy-and-general-safety-in-arv-naive-participants2026-03-05https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-with-radiation-therapy-in-metastatic-breast-cancer2026-03-20https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-discover-study2026-03-04https://www.askgileadmedical.com/docs/veklury/veklury-injection-site-reactions2026-03-20https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-bariatric-surgery2026-03-03https://www.askgileadmedical.com/docs/veklury/veklury-use-in-pediatric-patients2026-03-25https://www.askgileadmedical.com/docs/yeztugo/yeztugo-use-in-people-who-inject-drugs2026-03-04https://www.askgileadmedical.com/docs/veklury/veklury-hospital-readmission2026-03-25https://www.askgileadmedical.com/docs/veklury/veklury-bse-tse-statement2026-03-12https://www.askgileadmedical.com/docs/yeztugo/yeztugo-intramuscular-administration2026-03-18https://www.askgileadmedical.com/docs/veklury/veklury-handling-and-precautions2026-03-17https://www.askgileadmedical.com/docs/vosevi/biktarvy-use-in-participants-with-hiv-hcv-co-infection2026-02-23https://www.askgileadmedical.com/docs/epclusa/epclusa-resistance-profile2026-03-12https://www.askgileadmedical.com/docs/veklury/veklury-use-in-treatment-experienced-patients2026-02-24https://www.askgileadmedical.com/docs/veklury/veklury-use-with-imv-ecmo2026-03-17https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-oxcarbazepine2026-02-24https://www.askgileadmedical.com/docs/vemlidy/vem-effect-of-food2026-03-17https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-with-enfortumab-vedotin-in-patients-with-muc2026-02-24https://www.askgileadmedical.com/docs/epclusa/epclusa-treatment-interruption-adherence2026-03-17https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-gt-32026-03-09https://www.askgileadmedical.com/docs/trodelvy/trodelvy-impact-of-ugt1a1-status-on-safety-profile-in-patients-with-muc2026-03-04https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-weight-change2026-03-05https://www.askgileadmedical.com/docs/sunlenca/sunlenca-use-in-heavily-treatment-experienced-individuals2026-03-09https://www.askgileadmedical.com/docs/biktarvy/biktarvy-efficacy-and-safety-in-hiv-1-infected-virologically-suppressed-participants2026-03-04https://www.askgileadmedical.com/docs/trodelvy/trodelvy-1l-use-in-cisplatin-or-platinum-ineligible-muc2026-02-19https://www.askgileadmedical.com/docs/emtriva/emtriva-opening-or-splitting-of-capsules2026-02-18https://www.askgileadmedical.com/docs/epclusa/epclusa-oral-pellets-storage-and-stability-information2026-02-18https://www.askgileadmedical.com/docs/trodelvy/trodelvy-alternative-dosing-and-dosing-schedules-for-monotherapy2026-02-19https://www.askgileadmedical.com/docs/livdelzi/livdelzi-use-in-autoimmune-hepatitis-and-pbc-overlap2026-02-18https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-with-colorectal-cancer2026-02-25https://www.askgileadmedical.com/docs/descovy/descovy-crushing-or-splitting-of-tablets2026-02-17https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-buprenorphine2026-02-26https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-with-sclc2026-02-18https://www.askgileadmedical.com/docs/veklury/veklury-sars-cov-2-variants2026-03-02https://www.askgileadmedical.com/docs/trodelvy/trodelvy-incidence-and-management-of-diarrhea2026-02-17https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-patients-with-decompensated-cirrhosis2026-03-02https://www.askgileadmedical.com/docs/trodelvy/trodelvy-efficacy-by-trop-2-expression2026-02-19https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-with-brain-metastases-in-metastatic-breast-cancer-studies2026-02-27https://www.askgileadmedical.com/docs/truvada/truvada-crushing-or-splitting-of-tablets2026-02-17https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-hepatic-impairment2026-02-10https://www.askgileadmedical.com/docs/livdelzi/livdelzi-opening-or-splitting-capsules2026-02-11https://www.askgileadmedical.com/docs/vemlidy/vemlidy-lipid-abnormalities2026-02-11https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-1l-post-endocrine-therapy-in-hr%2B-her2-mbc2026-02-13https://www.askgileadmedical.com/docs/vemlidy/vemlidy-use-in-patients-with-hbv-and-hcv2026-02-13https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-patients-with-hcv-and-hbv2026-02-11https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-lipid-safety2026-02-11https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-people-with-hiv-22026-02-13https://www.askgileadmedical.com/docs/epclusa/epclusa-clinical-data-on-the-treatment-of-hepatitis-c-virus-genotypes-1-62026-02-24https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-renal-safety-profile-of-switching-from-ftc-tdf-for-hiv-1-prep2026-02-12https://www.askgileadmedical.com/docs/vemlidy/vemlidy-renal-safety-in-patients-with-chronic-hepatitis-b-virus-infection2026-02-24https://www.askgileadmedical.com/docs/vemlidy/vemlidy-fibrosis-improvement2026-02-12https://www.askgileadmedical.com/docs/livdelzi/livdelzi-treatment-interruption-and-adherence2026-02-20https://www.askgileadmedical.com/docs/veklury/veklury-nih-covid-19-treatment-guidelines2026-02-05https://www.askgileadmedical.com/docs/letairis/letairis-storage-and-stability-information2026-02-18https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-peritoneal-dialysis2026-02-06https://www.askgileadmedical.com/docs/complera/complera-crushing-or-splitting-of-tablets2026-02-20https://www.askgileadmedical.com/docs/epclusa/epclusa-use-for-8-weeks2026-02-09https://www.askgileadmedical.com/docs/livdelzi/livdelzi-pruritus-data2026-02-17https://www.askgileadmedical.com/docs/trodelvy/trodelvy-impact-of-ugt1a1-status-on-safety-profile-in-patients-with-mbc2026-02-09https://www.askgileadmedical.com/docs/biktarvy/biktarvy-hepatic-safety2026-02-14https://www.askgileadmedical.com/docs/veklury/veklury-solidarity-study2026-02-09https://www.askgileadmedical.com/docs/trodelvy/trodelvy-neutropenia-and-growth-factor-use-in-muc2026-02-19https://www.askgileadmedical.com/docs/epclusa/epclusa-minimal-monitoring-strategies2026-02-06https://www.askgileadmedical.com/docs/vemlidy/vemlidy-comparison-with-tdf2026-02-20https://www.askgileadmedical.com/docs/veklury/veklury-actt-1-study2026-02-06https://www.askgileadmedical.com/docs/epclusa/epclusa-stomach-intestinal-absorption-conditions2026-02-19https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-proton-pump-inhibitors2026-02-09https://www.askgileadmedical.com/docs/veklury/veklury-flushing-iv-line2026-02-05https://www.askgileadmedical.com/docs/veklury/veklury-hcpcs-j-code2026-02-06https://www.askgileadmedical.com/docs/livdelzi/livdelzi-coadministration-with-budesonide2026-02-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-storage-and-stability-of-injection-solution2026-01-22https://www.askgileadmedical.com/docs/livdelzi/livdelzi-coadministration-use-with-alcohol2026-02-12https://www.askgileadmedical.com/docs/livdelzi/livdelzi-mechanism-of-action2026-02-04https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-non-daily-dosing2026-02-10https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-older-patients-with-mbc2026-02-02https://www.askgileadmedical.com/docs/livdelzi/livdelzi-use-in-hepatic-impairment2026-02-11https://www.askgileadmedical.com/docs/biktarvy/biktarvy-effect-on-glucose-or-insulin2026-01-27https://www.askgileadmedical.com/docs/biktarvy/biktarvy-comparison-with-dtg-3tc2026-02-06https://www.askgileadmedical.com/docs/trodelvy/trodelvy-reports-of-ild-and-pneumonitis-with-monotherapy2026-01-29https://www.askgileadmedical.com/docs/trodelvy/trodelvy-combination-with-pembrolizumab-for-1l-treatment-of-mnsclc2026-02-09https://www.askgileadmedical.com/docs/trodelvy/trodelvy-efficacy-and-safety-by-trop-2-status-in-patients-with-hr%2B-her2-mbc2026-01-28https://www.askgileadmedical.com/docs/livdelzi/livdelzi-use-in-renal-impairment2026-02-05https://www.askgileadmedical.com/docs/stribild/stribild-crushing-or-splitting-of-tablets2026-02-03https://www.askgileadmedical.com/docs/tybost/tybost-crushing-or-splitting-of-tablets2026-01-13https://www.askgileadmedical.com/docs/trodelvy/trodelvy-laboratory-evaluation-of-trop-2-expression-prior-to-use-in-patients-with-mbc2026-02-03https://www.askgileadmedical.com/docs/vosevi/vosevi-crushing-or-splitting-of-tablets2026-01-21https://www.askgileadmedical.com/docs/livdelzi/livdelzi-switching-from-fibrates2026-02-04https://www.askgileadmedical.com/docs/trodelvy/trodelvy-vesicant-irritant-properties-and-extravasation2026-01-21https://www.askgileadmedical.com/docs/biktarvy/biktarvy-crushing-dissolving-or-splitting2026-01-31https://www.askgileadmedical.com/docs/sunlenca/sunlenca-baseline-resistance-testing2026-01-15https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-pregnancy2026-02-03https://www.askgileadmedical.com/docs/biktarvy/biktarvy-lipid-safety-profile2026-01-20https://www.askgileadmedical.com/docs/biktarvy/biktarvy-low-level-viremia2026-02-02https://www.askgileadmedical.com/docs/sunlenca/sunlenca-use-in-treatment-na%C3%AFve-individuals2026-01-19https://www.askgileadmedical.com/docs/genvoya/genvoya-crushing-or-splitting-of-tablets2026-01-31https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-in-people-who-inject-drugs2026-01-12https://www.askgileadmedical.com/docs/harvoni/harvoni-crushing-or-splitting-of-tablets-and-pellets2026-02-05https://www.askgileadmedical.com/docs/viread/viread-cutting-crushing-or-splitting-tablets2026-01-21https://www.askgileadmedical.com/docs/harvoni/harvoni-storage-and-stability-information2026-02-05https://www.askgileadmedical.com/docs/biktarvy/biktarvy-efficacy-by-adherence-subgroups2026-01-05https://www.askgileadmedical.com/docs/letairis/letairis-splitting-crushing-or-chewing-tablets2026-02-05https://www.askgileadmedical.com/docs/trodelvy/trodelvy-patient-reported-outcomes-in-1l-pd-l1-inhibitor-ineligible-mtnbc2025-12-16https://www.askgileadmedical.com/docs/sovaldi/sovaldi-crushing-or-splitting-of-tablets2026-01-21https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-1l-pd-l-1-inhibitor-ineligible-mtnbc2025-12-16https://www.askgileadmedical.com/docs/veklury/veklury-compatibility-with-alternative-diluents2026-01-28https://www.askgileadmedical.com/docs/livdelzi/livdelzi-use-in-primary-sclerosing-cholangitis2026-01-29https://www.askgileadmedical.com/docs/trodelvy/trodelvy-crossing-the-blood-brain-barrier2026-01-22https://www.askgileadmedical.com/docs/sunlenca/lenacapavir-investigational-use-with-islatravir2026-01-29https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-doxorubicin2026-01-14https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-dabigatran2026-01-14https://www.askgileadmedical.com/docs/vosevi/epclusa-harvoni-sovaldi-vosevi-use-in-active-tuberculosis-treatment2025-12-11https://www.askgileadmedical.com/docs/genvoya/descovy-for-post-exposure-prophylaxis2026-01-19https://www.askgileadmedical.com/docs/sunlenca/sunlenca-optimized-background-regimens-in-the-capella-study2026-01-09https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-effect-on-blood-pressure2025-12-10https://www.askgileadmedical.com/docs/trodelvy/trodelvy-pharmacokinetics2026-01-15https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-in-pediatric-and-adolescent-patients2026-01-20https://www.askgileadmedical.com/docs/sunlenca/sunlenca-treatment-emergent-resistance2025-12-09https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-on-dialysis2026-01-06https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-in-severe-renal-impairment-or-hemodialysis2025-12-09https://www.askgileadmedical.com/docs/yeztugo/yeztugo-body-mass-index2025-12-29https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-with-third-line-and-later-hr%2B-her2-mbc2025-12-09https://www.askgileadmedical.com/docs/biktarvy/biktarvy-rapid-start2025-12-15https://www.askgileadmedical.com/docs/trodelvy/trodelvy-mechanism-of-action2026-01-06https://www.askgileadmedical.com/docs/trodelvy/trodelvy-trophy-u-01-cohort-32025-12-23https://www.askgileadmedical.com/docs/trodelvy/trodelvy-neutropenia-and-growth-factor-use-in-mbc2025-12-16https://www.askgileadmedical.com/docs/vemlidy/vemlidy-use-in-severe-renal-impairment2025-12-15https://www.askgileadmedical.com/docs/livdelzi/livdelzi-switching-from-obeticholic-acid2025-12-08https://www.askgileadmedical.com/docs/sunlenca/sunlenca-use-in-severe-renal-impairment2025-12-08https://www.askgileadmedical.com/docs/veklury/veklury-use-in-severe-renal-impairment2025-12-02https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-hiv-2-pre-exposure-prophylaxis2025-12-10https://www.askgileadmedical.com/docs/sunlenca/sunlenca-safety-overview2025-11-24https://www.askgileadmedical.com/docs/biktarvy/biktarvy-bicstar-study2025-12-09https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-adults-aged-50-years2025-12-08https://www.askgileadmedical.com/docs/tybost/tybost-product-retirement2025-11-24https://www.askgileadmedical.com/docs/veklury/veklury-ph-of-the-final-solution2025-11-18https://www.askgileadmedical.com/docs/veklury/veklury-compatible-materials2025-11-19https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-methotrexate2025-12-05https://www.askgileadmedical.com/docs/biktarvy/biktarvy-baseline-resistance-testing2025-11-20https://www.askgileadmedical.com/docs/veklury/veklury-shaking-or-agitating2025-11-21https://www.askgileadmedical.com/docs/vemlidy/vemlidy-prophylaxis-for-patients-undergoing-chemotherapy-or-immunosuppressive-therapy2025-12-02https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-with-hepatic-impairment2025-11-24https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-patients-co-infected-with-hiv2025-12-01https://www.askgileadmedical.com/docs/trodelvy/trodelvy-real-world-data-in-mtnbc2025-11-18https://www.askgileadmedical.com/docs/veklury/veklury-osmolarity2025-11-19https://www.askgileadmedical.com/docs/vemlidy/vemlidy-use-in-acute-hepatitis-b2025-11-25https://www.askgileadmedical.com/docs/veklury/veklury-filters2025-11-18https://www.askgileadmedical.com/docs/veklury/veklury-overfill-during-dose-preparation2025-11-18https://www.askgileadmedical.com/docs/yeztugo/yeztugo-hiv-2-pre-exposure-prophylaxis2025-12-01https://www.askgileadmedical.com/docs/harvoni/epclusa-use-in-ldv-sof-treatment-experienced-patients2025-11-18https://www.askgileadmedical.com/docs/livdelzi/livdelzi-storage-and-stability2025-11-07https://www.askgileadmedical.com/docs/sunlenca/sunlenca-crushing-or-splitting-tablets2025-11-12https://www.askgileadmedical.com/docs/veklury/veklury-use-with-hydroxychloroquine-for-the-treatment-of-covid-192025-11-12https://www.askgileadmedical.com/docs/trodelvy/trodelvy-stability-of-unopened-vials-after-temperature-excursion-single-and-multiple-excursions-2025-11-07https://www.askgileadmedical.com/docs/biktarvy/biktarvy-treatment-emergent-rams2025-11-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-clinical-practice-guidelines2025-11-04https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-risperidone2025-11-04https://www.askgileadmedical.com/docs/vemlidy/vemlidy-crushing-or-splitting-of-tablets2025-11-11https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-carvedilol2025-11-03https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-modafinil2025-11-11https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-biktarvy2025-11-04https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-participants-with-baseline-resistance-overview2025-11-10https://www.askgileadmedical.com/docs/biktarvy/biktarvy-comparison-to-cab-%2B-rpv-im-q2m-injectable2025-11-03https://www.askgileadmedical.com/docs/trodelvy/trodelvy-sequencing-with-other-adcs-in-her2-mbc2025-11-10https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-with-her2%2B-bc2025-11-04https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-after-bariatric-surgery2025-10-28https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-eslicarbazepine2025-10-28https://www.askgileadmedical.com/docs/sunlenca/sunlenca-storage-and-stability-tablets-2025-10-24https://www.askgileadmedical.com/docs/descovy/descovy-storage-and-stability2025-11-03https://www.askgileadmedical.com/docs/biktarvy/biktarvy-weight-changes2025-10-28https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-endometrial-cancer2025-10-29https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-baseline-insti-resistance2025-10-21https://www.askgileadmedical.com/docs/veklury/veklury-use-in-pregnancy2025-10-22https://www.askgileadmedical.com/docs/trodelvy/trodelvy-patient-reported-outcomes-in-1l-pd-l1%2B-mtnbc2025-10-20https://www.askgileadmedical.com/docs/livdelzi/livdelzi-use-in-pediatrics2025-10-02https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-switching-from-truvada2025-10-20https://www.askgileadmedical.com/docs/veklury/veklury-osmolality-of-the-final-solution2025-10-02https://www.askgileadmedical.com/docs/cayston/cayston-storage-and-stability-information2025-10-02https://www.askgileadmedical.com/docs/yeztugo/yeztugo-switch-from-oral-prep2025-10-03https://www.askgileadmedical.com/docs/epclusa/epclusa-concomitant-use-of-proton-pump-inhibitors-at-high-doses-or-with-twice-daily-dosing2025-10-17https://www.askgileadmedical.com/docs/truvada/truvada-for-prep-hptn-0842025-10-03https://www.askgileadmedical.com/docs/veklury/veklury-storage-and-stability-of-lyophilized-powder2025-10-16https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-severe-renal-impairment-and-hemodialysis2025-10-16https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-baseline-pi-resistance2025-10-17https://www.askgileadmedical.com/docs/sunlenca/sunlenca-oral-initiation-dosing2025-09-30https://www.askgileadmedical.com/docs/biktarvy/biktarvy-central-nervous-system-penetration2025-10-02https://www.askgileadmedical.com/docs/harvoni/harvoni-oral-pellets-storage-and-stability-information2025-09-30https://www.askgileadmedical.com/docs/sunlenca/sunlenca-use-in-hepatic-impairment2025-10-02https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-digoxin2025-10-06https://www.askgileadmedical.com/docs/trodelvy/trodelvy-dose-modifications-in-mbc-studies2025-09-26https://www.askgileadmedical.com/docs/vemlidy/vemlidy-storage-and-stability-information2025-10-02https://www.askgileadmedical.com/docs/trodelvy/trodelvy-dose-modifications-in-muc-studies2025-09-26https://www.askgileadmedical.com/docs/odefsey/odefsey-crushing-or-splitting-of-tablets2025-09-30https://www.askgileadmedical.com/docs/yeztugo/yeztugo-hiv-testing2025-09-26https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-apixaban2025-10-06https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-early-breast-cancer2025-09-26https://www.askgileadmedical.com/docs/biktarvy/biktarvy-non-daily-dosing2025-10-07https://www.askgileadmedical.com/docs/epclusa/epclusa-risk-of-hbv-reactivation2025-10-06https://www.askgileadmedical.com/docs/vemlidy/vemlidy-bone-safety2025-10-13https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-duration-of-protection-after-last-dose2025-10-08https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-vaccines2025-09-18https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-vincristine2025-09-22https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-lithium2025-09-05https://www.askgileadmedical.com/docs/trodelvy/trodelvy-storage-and-stability-reconstituted-and-diluted-2025-09-19https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-lovastatin2025-09-16https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-pediatric-patients2025-09-27https://www.askgileadmedical.com/docs/sunlenca/sunlenca-pregnancy-and-breastfeeding2025-09-17https://www.askgileadmedical.com/docs/yeztugo/yeztugo-use-in-pediatrics-and-adolescents2025-09-12https://www.askgileadmedical.com/docs/biktarvy/biktarvy-viral-blips2025-09-26https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-people-who-inject-drugs2025-09-15https://www.askgileadmedical.com/docs/biktarvy/biktarvy-coadministration-with-metformin2025-09-05https://www.askgileadmedical.com/docs/yeztugo/yeztugo-mechanism-of-action2025-09-26https://www.askgileadmedical.com/docs/yeztugo/yeztugo-resistance2025-08-29https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-baseline-nnrti-resistance2025-09-03https://www.askgileadmedical.com/docs/vemlidy/vemlidy-serology2025-09-03https://www.askgileadmedical.com/docs/veklury/veklury-use-in-hepatic-impairment2025-09-16https://www.askgileadmedical.com/docs/yeztugo/yeztugo-use-in-individuals-switching-from-q2m-im-cab-for-prep2025-08-27https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-with-recurrent-glioblastoma2025-09-09https://www.askgileadmedical.com/docs/veklury/veklury-treatment-initiation-and-symptom-onset2025-08-25https://www.askgileadmedical.com/docs/veklury/veklury-pharmacokinetic-profile2025-09-11https://www.askgileadmedical.com/docs/veklury/veklury-simple-study-in-severe-covid-192025-08-25https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-hepatic-safety-profile2025-09-12https://www.askgileadmedical.com/docs/yeztugo/yeztugo-weight-changes2025-08-29https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-renal-impairment2025-09-16https://www.askgileadmedical.com/docs/yeztugo/yeztugo-renal-safety-profile2025-08-28https://www.askgileadmedical.com/docs/descovy/descovy-use-in-pregnancy-and-lactation2025-09-16https://www.askgileadmedical.com/docs/yeztugo/yeztugo-use-in-pregnancy-and-lactation2025-08-29https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-pediatric-patients2025-08-27https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-during-pregnancy-and-lactation2025-08-22https://www.askgileadmedical.com/docs/biktarvy/biktarvy-bic-dissociation-half-life2025-09-03https://www.askgileadmedical.com/docs/biktarvy/biktarvy-post-exposure-prophylaxis2025-08-18https://www.askgileadmedical.com/docs/yeztugo/yeztugo-lipid-safety-profile2025-09-02https://www.askgileadmedical.com/docs/sunlenca/sunlenca-administration-outside-the-dosing-window2025-08-20https://www.askgileadmedical.com/docs/trodelvy/trodelvy-and-incidence-of-alopecia2025-09-08https://www.askgileadmedical.com/docs/sunlenca/sunlenca-alternative-sites-of-administration2025-09-03https://www.askgileadmedical.com/docs/epclusa/epclusa-use-with-alcohol2025-08-18https://www.askgileadmedical.com/docs/yeztugo/yeztugo-adherence-data2025-08-29https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-hepatocellular-carcinoma2025-08-18https://www.askgileadmedical.com/docs/yeztugo/yeztugo-crushing-or-splitting-tablets2025-08-28https://www.askgileadmedical.com/docs/trodelvy/trodelvy-efficacy-and-safety-bytrop-2-status-in-patients-with-mtnbc2025-08-20https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-amoxicillin2025-08-27https://www.askgileadmedical.com/docs/epclusa/epclusa-svr4-and-svr242025-08-18https://www.askgileadmedical.com/docs/odefsey/descovy-taf-based-regimens-and-bone-safety2025-08-25https://www.askgileadmedical.com/docs/yeztugo/yeztugo-coadministration-with-gender-affirming-hormone-therapy2025-08-27https://www.askgileadmedical.com/docs/trodelvy/trodelvy-concentration-after-reconstitution2025-08-14https://www.askgileadmedical.com/docs/tybost/tybost-storage-and-stability2025-08-15https://www.askgileadmedical.com/docs/sunlenca/sunlenca-storage-and-stability-injection-2025-08-14https://www.askgileadmedical.com/docs/trodelvy/trodelvy-latex-content2025-08-21https://www.askgileadmedical.com/docs/harvoni/epclusa-use-post-heart-transplant2025-08-16https://www.askgileadmedical.com/docs/odefsey/odefsey-storage-and-stability2025-08-14https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-patients-previously-treated-with-glecaprevir-pibrentasvir2025-08-15https://www.askgileadmedical.com/docs/trodelvy/trodelvy-protection-from-light2025-08-22https://www.askgileadmedical.com/docs/vosevi/vosevi-storage-and-stability-information2025-08-15https://www.askgileadmedical.com/docs/epclusa/epclusa-use-post-lung-transplant2025-08-21https://www.askgileadmedical.com/docs/atripla/atripla-storage-and-stability2025-08-14https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-m184v-i-baseline-resistance2025-08-21https://www.askgileadmedical.com/docs/complera/complera-storage-and-stability2025-08-14https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-of-an-alternative-solution-for-reconstitution-and-dilution2025-08-12https://www.askgileadmedical.com/docs/stribild/stribild-storage-and-stability2025-08-14https://www.askgileadmedical.com/docs/genvoya/genvoya-storage-and-stability2025-08-14https://www.askgileadmedical.com/docs/yeztugo/yeztugo-storage-and-stability-of-tablets2025-08-11https://www.askgileadmedical.com/docs/emtriva/emtriva-storage-and-stability-information2025-08-14https://www.askgileadmedical.com/docs/yeztugo/yeztugo-use-in-hepatic-impairment2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-use-in-renal-impairment2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-bone-safety-profile2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-alternative-sites-of-administration2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-purpose-1-study2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-purpose-2-study2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-injection-site-reactions2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-oral-initiation-dosing-requirement2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-dosing-and-administration2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-administration-outside-the-dosing-window2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-tail-phase-pharmacokinetics2025-08-11https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-in-transgender-men2025-08-04https://www.askgileadmedical.com/docs/yeztugo/yeztugo-missed-dose2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-seroconversion2025-08-11https://www.askgileadmedical.com/docs/yeztugo/yeztugo-ongoing-studies-for-hiv-1-prep2025-08-11https://www.askgileadmedical.com/docs/biktarvy/viremic-events-on-biktarvy2025-07-31https://www.askgileadmedical.com/docs/sovaldi/sovaldi-storage-and-stability-information2025-07-29https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-ongoing-studies-in-cisgender-women2025-08-07https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-testosterone2025-07-28https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-bone-safety-profile2025-07-18https://www.askgileadmedical.com/docs/veklury/veklury-simple-study-in-moderate-covid-192025-07-29https://www.askgileadmedical.com/docs/vemlidy/vemlidy-switching-from-tenofovir-disoproxil-fumarate2025-07-29https://www.askgileadmedical.com/docs/trodelvy/trodelvy-efficacy-and-safety-by-her2-status-in-patients-with-hr%2B-her2-mbc2025-07-30https://www.askgileadmedical.com/docs/vosevi/hepatitis-c-virus-hcv-guidelines2025-07-29https://www.askgileadmedical.com/docs/sovaldi/sovaldi-oral-pellets-storage-and-stability-information2025-07-29https://www.askgileadmedical.com/docs/epclusa/epclusa-storage-and-stability-information2025-07-29https://www.askgileadmedical.com/docs/yeztugo/yeztugo-drug-interaction-profile2025-07-21https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-prazosin2025-07-17https://www.askgileadmedical.com/docs/trodelvy/trodelvy-combination-with-checkpoint-inhibitors-in-metastatic-breast-cancer2025-07-17https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-in-transgender-women-at-risk-of-acquiring-hiv-from-receptive-vaginal-sex2025-07-08https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-missed-doses-and-effect-on-efficacy2025-07-07https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-metastatic-castration-resistant-prostate-cancer-progressing-on-androgen-receptor-signaling-inhibitors2025-07-14https://www.askgileadmedical.com/docs/veklury/veklury-use-in-breastfeeding2025-07-01https://www.askgileadmedical.com/docs/veklury/veklury-outpatient-pinetree-study2025-07-01https://www.askgileadmedical.com/docs/trodelvy/trodelvy-impact-of-bmi-on-safety-and-efficacy2025-07-07https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-clinical-practice-guidelines2025-07-11https://www.askgileadmedical.com/docs/trodelvy/trodelvy-washout-period-prior-to-starting-treatment2025-07-16https://www.askgileadmedical.com/docs/biktarvy/biktarvy-coadministration-with-polyvalent-cations-containing-agents2025-07-15https://www.askgileadmedical.com/docs/trodelvy/trodelvy-peripheral-neuropathy2025-07-09https://www.askgileadmedical.com/docs/trodelvy/trodelvy-combination-with-pembrolizumab-and-chemotherapy-for-1l-treatment-of-mnsclc2025-07-07https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-in-hcv-monoinfection2025-06-30https://www.askgileadmedical.com/docs/yeztugo/yeztugo-coadministration-with-fluconazole2025-07-01https://www.askgileadmedical.com/docs/yeztugo/yeztugo-packaging-how-supplied-2025-06-24https://www.askgileadmedical.com/docs/yeztugo/descovy-for-prep-available-data-in-cisgender-women2025-06-27https://www.askgileadmedical.com/docs/biktarvy/biktarvy-therapeutic-drug-monitoring2025-06-18https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-renal-safety-profile2025-06-06https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-in-hbv-monoinfection-individuals2025-06-02https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-receptive-anal-sex-in-cisgender-women2025-06-19https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-use-in-diabetes2025-04-29https://www.askgileadmedical.com/docs/biktarvy/biktarvy-effects-of-adherence-on-pk2025-06-17https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-patients-with-metastatic-breast-cancer-and-leptomeningeal-carcinomatosis2025-06-12https://www.askgileadmedical.com/docs/descovy/descovy-for-prep-drug-concentration-rectal-tissue2025-04-04https://www.askgileadmedical.com/docs/hepsera/hepsera-product-retirement2025-06-19https://www.askgileadmedical.com/docs/trodelvy/trodelvy-ascent-study-in-metastatic-triple-negative-breast-cancer2025-06-05https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-in-ovarian-cancer2025-06-12https://www.askgileadmedical.com/docs/trodelvy/trodelvy-use-after-enfortumab-vedotin-in-muc2025-06-04https://www.askgileadmedical.com/docs/veklury/veklury-real-world-mortality-data2025-06-16https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-risankizumab-rzaa2025-05-22https://www.askgileadmedical.com/docs/sunlenca/sunlenca-coadministration-with-buprenorphine-naloxone2025-05-29https://www.askgileadmedical.com/docs/descovy/descovy-coadministration-with-rifamycins2025-06-06https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-naltrexone2025-05-29https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-during-lactation2025-06-05https://www.askgileadmedical.com/docs/veklury/veklury-long-covid-symptoms2025-05-20https://www.askgileadmedical.com/docs/veklury/veklury-use-in-immunocompromised-patients2025-06-06https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-vonoprazan2025-05-14https://www.askgileadmedical.com/docs/sunlenca/sunlenca-injection-site-reactions-overview2025-05-14https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-elevated-body-weight-or-body-mass-index-bmi-2025-06-03https://www.askgileadmedical.com/docs/veklury/veklury-use-in-rdv-treatment-experienced-patients2025-05-16https://www.askgileadmedical.com/docs/trodelvy/trodelvy-second-line-use-as-monotherapy-in-platinum-eligible-muc2025-05-22https://www.askgileadmedical.com/docs/epclusa/epclusa-use-without-ribavirin-in-decompensated-%0Acirrhosis2025-05-06https://www.askgileadmedical.com/docs/epclusa/epclusa-use-in-acute-hcv-infection2025-05-06https://www.askgileadmedical.com/docs/epclusa/epclusa-sofosbuvir-velpatasvir-%0Acoadministration-with-cannabinoids2025-05-09https://www.askgileadmedical.com/docs/biktarvy/biktarvy-storage-and-stability2025-05-07https://www.askgileadmedical.com/docs/odefsey/descovy-renal-safety-of-ftc-taf-containing-regimens-in-hiv-1-treatment2025-05-02https://www.askgileadmedical.com/docs/epclusa/epclusa-detectable-hcv-rna-during-therapy2025-05-01https://www.askgileadmedical.com/docs/sovaldi/epclusa-harvoni-sovaldi-vosevi-renal-safety2025-05-01https://www.askgileadmedical.com/docs/epclusa/epclusa-coadministration-with-fentanyl2025-05-02https://www.askgileadmedical.com/docs/vemlidy/vemlidy-kidney-transplant2025-05-02https://www.askgileadmedical.com/docs/truvada-prep/truvada-storage-and-stability2025-04-29https://www.askgileadmedical.com/docs/biktarvy/biktarvy-use-in-renal-transplant-patients2025-04-29https://www.askgileadmedical.com/docs/viread/viread-storage-and-stability-information2025-04-24https://www.askgileadmedical.com/docs/sunlenca/sunlenca-efficacy-against-hiv-22025-04-29https://www.askgileadmedical.com/docs/descovy-prep/descovy-coadministration-with-metformin2025-04-29https://www.askgileadmedical.com/docs/vemlidy/vemlidy-use-in-patients-post-orthotopic-liver-transplant2025-05-01https://www.askgileadmedical.com/docs/vemlidy/vemlidy-coadministration-with-rifampin2025-04-23https://www.askgileadmedical.com/docs/epclusa/epclusa-crushing-or-splitting-of-tablets-and-pellets2025-04-25https://www.askgileadmedical.com/docs/epclusa/epclusa-use-post-liver-transplant2025-04-18https://www.askgileadmedical.com/docs/biktarvy/biktarvy-efficacy-and-safety-by-baseline-cd42025-04-18https://www.askgileadmedical.com/docs/descovy-prep/descovy-coadministration-with-ritlecitinib2025-04-11https://www.askgileadmedical.com/docs/biktarvy/biktarvy-efficacy-and-safety-in-females2025-04-18https://www.askgileadmedical.com/docs/veklury/veklury-dosing-in-adults-weighing-40-kg2025-04-17https://www.askgileadmedical.com/docs/trodelvy/trodelvy-safety-analysis-by-exposure-adjusted-incidence-rates-in-hr%2B-her2-mbc2025-04-10https://www.askgileadmedical.com/docs/sunlenca/sunlenca-coadministration-with-enoxaparin2025-04-11https://www.askgileadmedical.com/docs/trodelvy/trodelvy-density-and-specific-gravity2025-04-07https://www.askgileadmedical.com/docs/trodelvy/trodelvy-type-of-infusion-bag-and-ancillary-infusion-equipment2025-04-07https://www.askgileadmedical.com/docs/biktarvy/biktarvy-bone-safety-profile2025-04-07https://www.askgileadmedical.com/conferences/covid-19/ESCMID-20262026-04-17https://www.askgileadmedical.com/conferences/hiv-aids/croi-20262026-02-22https://www.askgileadmedical.com/conferences/oncology/sabcs-20252025-12-09https://www.askgileadmedical.com/conferences/oncology/AACR-20252025-04-25https://www.askgileadmedical.com/conferences/liver-diseases/aasld-20252025-11-07https://www.askgileadmedical.com/conferences/hiv-aids/idweek-20252025-10-18https://www.askgileadmedical.com/conferences/hiv-aids/EACS 20252025-10-15https://www.askgileadmedical.com/conferences/oncology/ESMO-20252025-10-17https://www.askgileadmedical.com/conferences/oncology/wclc-20252025-09-06https://www.askgileadmedical.com/conferences/hiv-aids/IAS 20252025-07-13https://www.askgileadmedical.com/conferences/oncology/ESMO BC-20252025-05-14https://www.askgileadmedical.com/conferences/covid-19/ESCMID-20252025-04-11https://www.askgileadmedical.com/conferences/liver-diseases/EASL-20252025-05-07https://www.askgileadmedical.com/conferences/oncology/asco-20252025-05-30https://www.askgileadmedical.com/publications/?Product=atripla2023-08-24https://www.askgileadmedical.com/publications/?Product=biktarvy2023-08-24https://www.askgileadmedical.com/publications/?Product=cayston2023-08-24https://www.askgileadmedical.com/publications/?Product=complera2023-08-24https://www.askgileadmedical.com/publications/?Product=descovy2023-08-24https://www.askgileadmedical.com/publications/?Product=descovy-for-prep2023-08-24https://www.askgileadmedical.com/publications/?Product=emtriva2023-08-24https://www.askgileadmedical.com/publications/?Product=epclusa2023-08-24https://www.askgileadmedical.com/publications/?Product=genvoya2023-08-24https://www.askgileadmedical.com/publications/?Product=harvoni2023-08-24https://www.askgileadmedical.com/publications/?Product=letairis2023-08-24https://www.askgileadmedical.com/publications/?Product=livdelzi2023-08-24https://www.askgileadmedical.com/publications/?Product=odefsey2023-08-24https://www.askgileadmedical.com/publications/?Product=sovaldi2023-08-24https://www.askgileadmedical.com/publications/?Product=stribild2023-08-24https://www.askgileadmedical.com/publications/?Product=sunlenca2023-08-24https://www.askgileadmedical.com/publications/?Product=tecartus2023-08-24https://www.askgileadmedical.com/publications/?Product=trodelvy2023-08-24https://www.askgileadmedical.com/publications/?Product=truvada2023-08-24https://www.askgileadmedical.com/publications/?Product=truvada-for-prep2023-08-24https://www.askgileadmedical.com/publications/?Product=tybost2023-08-24https://www.askgileadmedical.com/publications/?Product=veklury2023-08-24https://www.askgileadmedical.com/publications/?Product=vemlidy2023-08-24https://www.askgileadmedical.com/publications/?Product=viread2023-08-24https://www.askgileadmedical.com/publications/?Product=vosevi2023-08-24https://www.askgileadmedical.com/publications/?Product=yescarta2023-08-24https://www.askgileadmedical.com/publications/?Product=yeztugo2023-08-24https://www.askgileadmedical.com/publications/?Product=zydelig2023-08-24https://www.askgileadmedical.comhcp/documents/conferences/Orkin_CROI2026_Oral_ART-1%20Primary_Final%20NO%20QR_24Feb26@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HDV_BLV_Wyles_MYR301%20W240%20Participants%20with%20HIV%20oral%20presentation_PRESENTED@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/ESMO%202025_EVOKE-01%20poster_March2026@pdf2025-10-17https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_521_Hansen_GS-3242%20Virology@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Gupta_CROI_2026_Oral_GS-3242%20Ph1a%20and%201b_20260223@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Hedgcock_CROI26_Pos_ART-1%20Ph2%20Wk96%20Eff-saf_Submission_16Feb26@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Coming%20Soon%20(1)2024@pdf2026-04-17https://www.askgileadmedical.comhcp/documents/conferences/Moore_CROI%202026_L4%20Math%20Modeling%20ePoster_13Feb2026_submitted@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_LEN_581_Margot_LEN%20CA%20polymorphisms_@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_GS-3242_490_Subramanian_GS-3242%20Nonclinical%20ADME@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Tao_CROI%202026_L4P%20Concomitant%20Medications%20ePoster_DV-008782_submitted_16Feb2026@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_LEN%20TAB%20ZAB_567_VanderVeen_LEN%20TAB%20ZAB%20Ph2%20W52%20Resistance@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/CROI-Poster_NP%20Gumede_2026@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_ISL+LEN_516_Colson_ISL+LEN%20Ph2%20W96%20Efficacy%20and%20Safety@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Cox_CROI%202026_PURPOSE%20resistance_oral_final_uneditable@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Ndlovu_CROI%202026_P1%20end%20of%20RBP_23%20Feb%202026_Final_uneditable@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Cantos_CROI%202026_P2%20end%20of%20RBP%20oral_23%20Feb%202026_Final%20uneditable@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_Cure_Selzer_Fresh_Presented%201@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_Cure_Workowski_ABFPoster_Presented@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Meissner_CROI26_Pos_ART-2%20primary_Submission_12Feb26@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Natukunda_CROI26_Pos_BFTAF%20peds%20C4%20WK24_Submission_13Feb26@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_LEN_539_Ogbuagu_LEN%20RW%20Effectiveness@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/Hughes+CROI2026+Q12M+MIDD+dose+selection+Poster@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_LEN+TAB+ZAB_517_Gaur_LTZ%20Ph2%20W52%20PROs@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/2026_CROI_HIV_ISL+LEN_586_Bekerman_ISL+LEN%20Ph2%20W96%20Resistance@pdf2026-02-22https://www.askgileadmedical.comhcp/documents/conferences/RF6-05-ASCENT-03%20PROs_SABCS_2025_Punie_Final@pdf2025-12-09https://www.askgileadmedical.comhcp/documents/conferences/SABCS_2025_PS50329%20Chou%20inSiGht%20TNBC@pdf2025-12-09https://www.askgileadmedical.comhcp/documents/conferences/2025_SABCS_Trodelvy_Jhaveri_ASCENT-07%20Primary_Final_9Dec2025@pdf2025-12-09https://www.askgileadmedical.comhcp/documents/conferences/2025_BC_Trodelvy_SABCS_PS5-02-28_Kalinsky_ASCENT-04%20Safety%20Analysis_Final_09Dec25@pdf2025-12-09https://www.askgileadmedical.comhcp/documents/conferences/2025_SABCS_BC_Trodelvy_PS1-13-24_Hurvitz_ASCENT-03%20Safety%20Analysis_Final_09Dec2025@pdf2025-12-09https://www.askgileadmedical.comhcp/documents/conferences/AASLD%202025_HDV_Asselah_MYR204_301_IntVirol_Poster_PRESENTED@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_HBV_Li_1313_Unglycosylated%20HBsAg_Poster_Final@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/AASLD%202025_HDV_Nierhoff_BLV%20Persistency%20Germany_Poster_Presented@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_PBC_Seladelpar_5031_Bowlus_ASSURE%20FibroScan%20LB%20poster%20_FINAL@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/AASLD%202025_HDV_Lampertico_Adelphi%20HDV%20Patient%20Burden_Poster_PRESENTED@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_PBC_Seladelpar_4471_Kumar_PBC-40%20General%20Health%20and%20Wellbeing%20poster_FINAL@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/AASLD%202025_HDV_Kumar_6162%20Arm%20D%20PK%20PD%20safety_poster_PRESENTED@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_PBC_Seladelpar_4438_Jones_MAIC_Draft+5_3-11-2025_SUBMITTED@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_PBC_Seladelpar_5037_Bowlus_%20OCA%20late-breaking%20poster_FINAL@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_PBC_Seladelpar_4505_Kremer_RESPONSE%205-D%20Itch%20poster_FINAL@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/AASLD%202025%20ASSURE%20Improvement%20in%20Pruritus%20LB%20Oral_final_PRESENTED@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_PBC_Seladelpar_4459_Kumar_RESPONSE%20Elevated%20Bilirubin%20poster_FINAL@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/AASLD%202025%20ASSURE%20Pooled%20Efficacy%20%20Safety%20Oral_final_PRESENTED@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/AASLD%202025_HDV_Zoulim_Low%20viremic%20relapse%20after%20BLV_Poster_PRESENTED@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_HCV_Makhija_3058_Implications%20of%20the%20New%20AASLD-IDSA%20HCV%20Comedications_Poster_Final@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/AASLD%202025_HDV_Lampertico_Integrated%20bile%20acid%20safety_poster_PRESENTED@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_MASH_CILO-FIR-SEMA_0148_Alkhouri_WAYFIND%20Primary%20Oral_3Nov2025_Presented@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_PBC_Seladelpar_4434_Gordon_%20ASSURE%20RESPONSE%20rollover%20poster_FINAL@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_HBV_0197_Gane_GS-2829%20GS-6779_Oral_Final@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_HBV_Kim_1278_TDF%20TAF%20HCC%20Risk_Poster_Final@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_HCV_Chappell_1380_SofosbuvirVelpatasvir%20exposure%20in%20pregnant%20women_Poster_Final@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/2025_IDWeek+2025_HIV_BVY_Dunbar_Global+Survey+Poster_Presented@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/2025_AASLD_HCV_Bourlière_1430_HCV%20Concordance_Poster_Final@pdf2025-11-07https://www.askgileadmedical.comhcp/documents/conferences/Li_IDWeek2025_poster_CDRG_Final@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Chastek_IDWeek25_Poster_OPTUM%20change%20or%20restart_Final_3Oct25@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Lim_IDWeek2025_Poster_HealthVerity%20Adh%20Restart_29Sep25@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/2025_IDW_CoV_ODV_P1231_Amini_Ph1PKODVRIPos_FINAL@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Potoane_IDWeek2025poster_LEN%20PK%20contraceptive_FINAL@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Gupta_IDWeek25_Poster_EMPOWER%20PRO_Final_6Oct25@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Niu_IDWeek2025_poster_ISL%20LEN%20rBA%20Food%20Effect_20251007@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Blumenthal_IDWeek25_poster_P2%20LEN%20GAHT%20PK%20safety_13Oct2025@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/2025_IDW_CoV_ODV_P1169_Moshiri_RSVMingenomePos_FINAL@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Walmsley_IDWeek25_poster_EMPOWER%20eff%20saf_30Sept2025@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Mordi_EACS2025_poster_ART%20Persistence%20with%20MH%20and%20PDC_Final@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/2025_IDW_CoV_RDVODV_P1276_Rodriguez_VariantsPos_FINAL@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Workowski_IDWeek%202025%20poster_LEN%20TAB%20ZAB%20pooled%20safety_15Oct25@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/2025_IDW_MGV_ODV_P1166_Chang_MarburgvirusPos_FINAL@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Avihingsanon_EACS2025_poster_P2%20Commons%20meds%20safety_Final_3Oct@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/2025_IDW_CoV_ODV_P1232_Amini_RSVODVDosePos_FINAL@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/2025_IDW_CoV_RDV_P1625_Rodriguez_RedpineVLPos_FINAL@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/2025_IDW_CoV_RDV_P1632_Godwin_RDVHepaticPos_FINAL@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Zhang_IDWeek2025_Poster_LEN+TAB%20and%20ZAB%20Ph2%20W52%20PK%20ADA_Final_09Oct25@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/2025_IDWeek_HDV_BLV_Lampertico_P-2195_HBV%20Responses%20W96%20144%20Integrated%20poster_SUBMITTED@pdf2025-10-18https://www.askgileadmedical.comhcp/documents/conferences/Rockstroh_EACS25_poster_Late%20HIV%20diagnosis%20pooled%20analysis_Final_01Oct25@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Colson%20et%20al_EACS%202025_presentation_ISL+LEN%20Ph2_W48_Final_16Oct@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Arora_EACS25_Poster_BVY%20SWITCH%20PK_Final_3Oct25@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Eron_EACS2025_Poster_ISL%20LEN%20Week+48%20PRO_Final_08Oct25@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Ogbuagu_EACS2025_oral_PURPOSE%202%20persistence_Final_16Oct25_uneditable@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Janjigian_EDGE-GastricA1_ESMO_Oral_v1@3_17Oct25@pdf2025-10-17https://www.askgileadmedical.comhcp/documents/conferences/de%20Wet_EACS2025_Poster_BICSTaR%2060M+_Final_2Oct25@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/2025_ESMO_Lung_Trodelvy%20DZ_Ahn_VELOCITY-Lung_SS01_Poster_For%20Print@pdf2025-10-17https://www.askgileadmedical.comhcp/documents/conferences/DAntoni_EACS25_Poster_BIC%20LEN%20Hig%20resistance_Final_2Oct25@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/LBA22_de%20Azambuja_ASCENT-04%20PRO%20mini-oral_D7_17OCT2025_STC@pdf2025-10-17https://www.askgileadmedical.comhcp/documents/conferences/Molina_EACS2025_oral_P5%20Diversity%20recruitment_Final_16Oct_uneditable@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/2025_ESMO_BC_Trodelvy_Cortes_ASCENT-03%20primary%20PFS_oral_Final_18OCT2025@pdf2025-10-17https://www.askgileadmedical.comhcp/documents/conferences/Hedgcock_EACS25_Poster_BICLE%20P3%20Demograph_Final_29Sep25@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Zeggagh_EACS25_poster_injectable%20PrEP%20in%20France_Final@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Arora_EACS25_Poster_BIC%20LEN%20DDI_Final_02Oct25@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Ogbuagu_EACS%202025%20Presentation_LTZ%20Ph2%20W52%20Efficacy_Safety_16Oct25_Final@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/Dong_EACS%202025_Oral%20Presentation_FRESH%20AEs_Final_15OCT2025@pdf2025-10-15https://www.askgileadmedical.comhcp/documents/conferences/2025_WCLC_Lung_Trodelvy_Dowlati_EVOKE-04-TIP_Poster@pdf2025-09-06https://www.askgileadmedical.comhcp/documents/conferences/Garassino_AACR2025_NSCLC_EVOKE-01_Trop2%20Biomarker%20Analysis_Poster_FINAL%20(2)@pdf2025-04-25https://www.askgileadmedical.comhcp/documents/conferences/2025_Lung_Trodelvy-Patel_EVOKE-02_AACR_PosterFinal@pdf2025-04-25https://www.askgileadmedical.comhcp/documents/conferences/Bekker_IAS2025_presentation_LEN%20Special%20TB%20and%20Beyond_Final@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Kelley_IAS2025_Presentation_bHIV%20counterfactual%20oral_Final@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Cai_IAS2025_Poster_FRESH%20VES%20PD%20cytokine%20response_Final_09JUL2025@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Cai_IAS2025_Presentation_LTZ%20Biomarkers_Final_26Jun25@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Gaur_IAS2025_Poster_LEN%20LTZ%20Ph2%20W26%20PROs_24Jun25@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Nyamaizi_IAS2025_ePoster_P1%20qualitative%20acceptability_Final_11July@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/BICTARG%20POSTER%20IAS%202025@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Chuo_IAS2025_Poster_BVY%20HBV%20HIV%20Coinfection_Final_08Jul25@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Bekker_IAS2025_Presentation_P1%20Pregnancy%20E%20S%20PK_Final@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Gill_IAS2025_Presentation_P1%20P2%20young%20people%20E%20S%20PK_Final@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Dong_IAS2025_ePoster_FRESH%20Lessons%20Learned_Final_25June25@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Mngadi_IAS2025_Presentation_P2%20PROs_Final@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Mujuru_IAS2025_Poster_FTAF%20peds_Final_08Jul25@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Mansoor_IAS2025_Poster_P1%20PRO_Final_11Jul25@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/Palanee%20Phillips_IAS2025_Poster_P1%20Womens%20Choice%20Qual_Final_11Jul25@pdf2025-07-13https://www.askgileadmedical.comhcp/documents/conferences/2025_ASCO_BC_Trodelvy_Tolaney_ASCENT-04%20Oral_30May2025_Final_Unbranded@pdf2025-05-30https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_HDV_Liu_FRI-290_NTCP%20IntPoly_Poster_Final@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/2025%20ASCO_Lung_SG_8522_Felip_EVOKE-01%20BMX%20poster_For%20upload@pdf2025-05-30https://www.askgileadmedical.comhcp/documents/conferences/2025%20ASCO_Lung_SG_8599_Reinmuth_EVOKE-01%20LTFU_For%20upload@pdf2025-05-30https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_HDV_Buti_THU-258_DSPAdherence_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL_2025_HCV_Aleman_WED-276_SVR10K_Final@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/2025_ESMO%20BC_BC_Trodelvy_345P_Rugo_BC%20Pooled%20Safety_Final_06May25@pdf2025-05-14https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_PBC_Gulamhusein_WED-171_Cirrhosis%20PHT_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/ESMO-BC-2025-Poster-TROPSPAIN_v2@0%2006May2025@pdf2025-05-14https://www.askgileadmedical.comhcp/documents/conferences/2025_EASL_HDV_BLV_OS-066_Aleman_Predictors%20of%20Non-Relapse_Oral_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_HDV_Kumar_WED-312_Hepatic%20ImpairC_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_PBC_Zhou_FRI-317_%20Renal%20Impair_%20Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL_2025_HBV%20Cure_Gane_THU-246_Vaccine%20Phase%201a_Final@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL_2025_HBV_Lim_WED-296_reREACH-B_Final@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/2025_EASL_HDV_BLV_LBO-004_Wedemeyer_MYR301%20W240_Oral_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_HDV_Kumar_WED-311_Peds%20modeling_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/2025_EASL_HDV_BLV_OS-070_Zoulim_TDvsTND_Oral_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_HDV_Brunetto_WED-308_MYR%20301%20W144%20LSM%20NIT_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL_2025_HBV_Lim_WED-300_PAGED-B_Final@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_PBC_Villamil_THU-274_Prior%20tx_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_HDV_Kumar_WED-313_Renal%20Impairment%20Arm%20B_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_PBC_Levy_THU-291_NumRateScale_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_HDV_Buti_WED-029_MYR%20301%20144wk%20EQ5D%20VAS_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/2025_ESCMID_CoV_RDV_Berry_EarlyLateNoRDVPos_P0423_FINAL@pdf2025-04-11https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_HDV_Kumar_WED-310_Viral%20load_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_PBC_Hansen_THU-286_RESPONSE%20GLOBE%20Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL_2025_HCV_Makhija_WED-031_DDI%20Study_Final@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_PBC_Kremer_THU-277_PsPruritis_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/EASL%202025_PBC_Jones_THU-294_Pruritus%20Pool%201_Poster_FINAL@pdf2025-05-07https://www.askgileadmedical.comhcp/documents/conferences/2025_ESCMID_CoV_RDV_Dickinson_ImpactsCOV19_P0514_Presented@pdf2025-04-11https://www.askgileadmedical.comhcp/documents/conferences/2025_ESCMID_CoV_ODV_Hedskog_P0425_BIRCHPos_Finalv2@pdf2025-04-11https://www.askgileadmedical.comhcp/documents/conferences/2025_ESCMID_CoV_ODV_Rodriguez_OAKTREEPos_Presented@pdf2025-04-11https://www.askgileadmedical.com/docs/conference/2025_AACR_BC_Trodelvy_T-02%20ctDNA_Final_07Apr2025@pdf2025-04-25